Gene predicts breast cancer metastasis:
This article was originally published in Clinica
US researchers have identified a gene marker that can predict the likelihood of breast cancer metastasis in patients who become resistant to the anti-hormone drugs aromatase inhibitors. The team, based at the Fox Chase Cancer Center in Philadelphia, Pennsylvania, found that high levels of the gene CEACAM6 (carcinoembryonic antigen-related cell adhesion molecule 6) were expressed in breast tumours that were likely to become invasive and metastasise. The marker could help predict which patients have the greatest risk of breast cancer recurrence so their doctors can offer the most appropriate treatment plan, said the investigators. The findings were presented at the 2007 annual meeting of the American Association for Cancer Research, in Los Angeles, California, this month.
You may also be interested in...
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.